TipRanks
Go Ultimate55% OFF

TScan Therapeutics (TCRX) Balance Sheet

TScan Therapeutics Balance Sheet

TScan Therapeutics's total assets for Q2 2026 were $171.45M, a decrease of 15.12% from the previous quarter. TCRX total liabilities were $102.43M for the fiscal quarter, a 2.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 228.79M$ 371.12M$ 272.15M$ 199.09M$ 188.11M
$ 105.67M$ 130.15M$ 121.28M$ 99.66M$ 27.33M
$ 123.12M$ 240.97M$ 150.87M$ 99.43M$ 160.78M

Currency in USD

TScan Therapeutics Debt to Assets

0150M300M450M0 %80 %160 %240 %LiabilitiesDebt to Assets2019202020212022202320242025AssetsLiabilitiesDebt to Assets